The Lake Forest Library has completed another phase of its long-term building rehabilitation project and is now preparing for the next chapter of improvements. Last month, the library finished ...
Avenger Flight Group (“Avenger” or the “Company”), a leading global provider of advanced flight simulation training solutions for commercial airlines, today announced that it has successfully ...
Penn researchers found that psilocybin can calm brain circuits tied to pain and mood, easing both physical suffering and emotional distress in animal studies. The compound works in the anterior ...
Eli Lilly has handed AC Immune 10 million Swiss francs ($12.5 million) to expand their Alzheimer’s disease collaboration as a candidate moves closer to the clinic. The U.S. pharma first tapped up AC ...
BOISE, Idaho — Athletic Club Boise's inaugural season is underway, and fans who did not secure their season tickets will soon be able to buy single-game tickets for the team's first-ever home game on ...
Ross Mathews is expanding his hosting duties. The “RuPaul’s Drag Race” judge and Drew Barrymore’s talk show co-anchor is the new host of “90 Day: The Single Life: Tell All” on TLC. The two-part ...
AI agent design patterns provide a structured approach to building intelligent systems that address diverse challenges in automation and workflow optimization. As highlighted by Google Cloud Tech, ...
Johnson & Johnson has paused further enrollment in a phase 2b trial of its AC Immune-partnered Alzheimer’s disease candidate, leaving analysts to speculate recruitment challenges may be the culprit.
American culture has developed a curious habit of turning ordinary life into pathology. Shyness becomes social anxiety. Stress is labeled trauma. Sadness is quickly upgraded to depression. And now — ...
An onboard charger converts power between the power grid and electric vehicles or hybrid electric vehicles. Traditional systems use two stages of power conversion: a boost converter to implement unity ...
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study This randomized, parallel-group, phase II study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results